Researchers at the University of Pennsylvania School of Medicine have found that women taking weight loss medications like Ozempic may be 30% less likely to develop breast cancer. This study adds to the evidence suggesting these drugs could have cancer prevention properties.
Our neutral summary
Researchers at the University of Pennsylvania School of Medicine have found that women taking weight loss medications like Ozempic may be 30% less likely to develop breast cancer. This study adds to the evidence suggesting these drugs could have cancer prevention properties.
The reporting belongs to New York Post; we don't reproduce it.
No note attached
on this article.
Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study
Study suggests weight loss drugs may reduce breast cancer risk